SCHEMBL30289595

SCHEMBL30289595

COc1ccc(CN(Cc2ccc(OC)cc2)c2nccc3cnc(-c4ccc(Oc5ccccc5)c(F)c4)n23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 3/20 0.38
LPAR5 Q9H1C0 3/20 0.38
PPARD Q03181 1/20 0.35
CYP19A1 P11511 1/20 0.35
FFAR1 O14842 1/20 0.35
PTGES O14684 1/20 0.35
MET P08581 4/20 0.35
CETP P11597 1/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
MST1R Q04912 2/20 0.34
HGF P14210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30289586 0.90 LPAR1 (0.44) LPAR1LPAR5CYP19A1MEN1ALDH1A1
SCHEMBL30289608 0.88 MEN1 (0.43) CYP19A1MEN1ALDH1A1KMT2AKDM4E
SCHEMBL30289624 0.84 CETP (0.37) LPAR1LPAR5CETPMEN1ALDH1A1
SCHEMBL30289633 0.84 CETP (0.37) CETPMEN1ALDH1A1KMT2AKDM4E
SCHEMBL30289647 0.83 CYP1A2 (0.40) METCETPMEN1ALDH1A1KMT2A
SCHEMBL30289703 0.80 MEN1 (0.39) CYP19A1MEN1ALDH1A1KMT2AKDM4E
SCHEMBL30289614 0.76 ABL1 (0.59) MST1RKDR
SCHEMBL30367508 0.74 LMNA (0.42) MEN1ALDH1A1KMT2AHPGDRAB9A
SCHEMBL30289651 0.65 FYN (0.61) MEN1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL23647531 0.64 LTA4H (0.55) LPAR1LPAR5MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115894497-A Imidazopyrimidine compounds, and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-04-04 CN disclosed